Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Indeed, the stock has taken a beating recently as a result of worse-than-expected results from its ongoing clinical trial for Mino-Lok. In fact, it has already received a Qualified Infectious Disease Product (QIDP) designation from the U.S. Food and Drug Administration (FDA). Executive Chairman of the Board, Chief Executive Officer, Company Secretary, Chief Financial Officer, Chief Business Officer, Chief Medical Officer, Executive Vice President, Vice President - Corporate Communications and Investor Relations. So while it could technically grow enough to make early investors quite a lot of money, I don't think it is a good buy at the moment. Copyright 2023 MarketWatch, Inc. All rights reserved. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.48% per year. Disclaimer: This doesn't confirm or . You demand trustworthy DD for free from user of free stocks platform. Got a confidential news tip? Research, Inc. nor its Information Providers can guarantee the accuracy, Long term is incredible due to great stock. Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a Cranford, New Jersey based late-stage drug concern focused on the development of therapies that are typically reformulations of previously approved . The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ. Picking up a position in a healthcare stock ahead of a major catalyst can be a risky strategy but is also one that serves up the potential for a high degree of reward on the Citius Pharmaceuticals IncMino-LokMino-WrapHalo-LidoNoveCiteI/ONTAKI/ONTAKIL-2TMino-LokHalo-LidoMino-WrapNoveCiteARDS, Citius Pharmaceuticals Inc stock price live 1.650, this page displays NASDAQ CTXR stock exchange data. The Hangout. $1.64 No cost, no obligation to buy anything ever. Zacks Ranks stocks can, and often do, change throughout the month. ET to 3:30 p.m. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Sign Up to See Zacks Style Scores Education - Learn more about the Zacks Style Scores. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. 7.4k. We want to hear from you. The Zacks Rank has been called the Billion Dollar Secret. Daily Stock Discussion - Friday June 25, 2021 : r/SPCE. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Vi, Yahoo, r en del av Yahoos varumrkesfamilj. We use cookies to understand how you use our site and to improve your experience. Price as of April 17, 2023, 10:00 a.m. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Prospective CTXR stock investors deserve a much more in-depth discussion of this fascinating company. Welcome to the CTXR Daily Discussion Thread! Last Five Real-Time Trades. Source: Kantar Media. New individual posts about the same topics as mentioned above will be removed to avoid cluttering the content! Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Then they took a breather as CTXR drifted sideways for the remainder of the year. Let's do some quick math to see if that might be enough to make millions. Is It Too Late to Buy Citius Pharmaceuticals Stock? You can unlock it all now. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. See the Full List of Stocks To Beat Earnings. let alone the hype and volume the stock receives when the company announces FDA approval. In addition, H.C. Wainwright has issued a price target of . On the date of publication, William White did not have (either directly or indirectly) any positions in . Klicken Sie auf Alle ablehnen, wenn Sie nicht mchten, dass wir und unsere Partner Cookies und personenbezogene Daten fr diese zustzlichen Zwecke verwenden. the Web site, including, but not limited to Information originated by Zacks Citius has four programs in its pipeline, two of which are in clinical trials and thus the most relevant for investors over the next year or so. Citius Pharmaceuticals Inc. (CTXR) stock is currently valued at $1.57. Created . 1st floor. This includes personalizing content and advertising. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from sorry guys. Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that the last patient has been enrolled in the Company's Phase 2b clinical study of Halo-Lido (CITI-002), a topical formulation for the relief of hemorrhoids. The stock could grow by quite a bit over the next 10 years, but it's a gamble. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. share. The technique has proven to be very useful for finding positive surprises. Have Watchlists? CTXR is not currently paying a regular dividend. Posted by. 966. . Copyright 2023. 2023 InvestorPlace Media, LLC. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Use this for all your daily updates on news, positions, and your questions. All rights reserved. No significant news for in the past two years. Alex Carchidi has no position in any of the stocks mentioned. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. On Penny Stocks and Low-Volume Stocks:With only the rarest exceptions,InvestorPlacedoes not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. Citius Pharmaceuticals Inc stock price live 1.650, this page displays NASDAQ CTXR stock exchange data. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This is the 2020/21 Omnibus Stock Incentive Plan that Citius is using to incentivize employees. Source: FactSet. 23. Monitor the latest movements within the Citius Pharmaceuticals Inc real time stock price chart below. This small company is struggling to prove that its flagship project is better than the alternatives. Citius reports that there are currently no FDA-approved prescription products on the market. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. To see all exchange delays and terms of use, please see disclaimer. And, with enough luck, someday those nascent businesses might grow to become formidable companies with budding rosters of life-saving drugs. Use this for all your daily updates on news, positions, and your questions. Participation from Market Makers and ECNs is strictly . Klicka p Avvisa alla om du inte vill att vi och vra partner ska anvnda cookies och personuppgifter fr dessa ytterligare ndaml. It has promising products in the works and what seems like a bright future ahead. HQ: 11 Commerce Dr Fl 1 Cranford, 07016-3501 New Jersey. See Zacks' latest analysis free. CTXR Stock 12 Months Forecast. publicly available sources. 8.7k. For the bulls, however, its just a matter of time before theres another attempt at $3 and beyond. Certainly, those two developments set the company up well. Data is a real-time snapshot *Data is delayed at least 15 minutes. Daily Stock Discussion - Tuesday June 29th, 2021. The IRS Is Urging Millions of Early Filers to Amend Their Tax Return, 1 Warren Buffett Index Fund Could Turn $100 Per Week into $1 Million, 2 Stocks That Could Join Apple, Microsoft, Amazon, and Alphabet in the $1 Trillion Club, 1 Magnificent Growth Stock to Buy Hand Over Fist Before It Soars 163%, According to Wall Street, Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research, Motley Fool Issues Rare All In Buy Alert, Copyright, Trademark and Patent Information. View real-time stock prices and stock quotes for a full financial overview. Buying shares of early stage biotech companies is one of the ways that cash-strapped investors can plant the seeds of massive growth. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Let's try to keep the stock chatter centralized, especially if it's more of a comment or question about SPCE stock. Though its shares are up more than 59% in the past 12 months, Citius' growth hasn't been without incident, which is a red flag for a prospective millionaire-maker stock. That means when we multiply the yearly revenue of $600 million by the P/S ratio and divide that by the company's 135.47 million shares outstanding, we get an estimated price of $35.83. Company Profile. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Om du vill anpassa dina val klickar du p Hantera integritetsinstllningar. CTXR is my largest swing trade. Then introduce the worlds market.. its current market cap is 450m at a $3.60 share price. Invest better with The Motley Fool. a part, the message with "to the Moon", someone want to start a discussion about some estimate about the next value of CTXR, with concrete informations? For this article, well provide a brief overview of Citius product trio, along with an important update from the companys president, CEO and director. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. If you do not, click Cancel. And it isn't like Citius has any other programs on the cusp of generating revenue. It has nothing to do with other company proceedings. The average price target represents a 227.87% change from the last price of $1.53. All 'A' Rated Buy Stocks, 3 Thriving Tech Stocks to Buy Hand over Fist Now, 3 Top of The Line Stocks to Buy This Month, Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids, Citius Pharmaceuticals Advances Efforts to Spin Off Oncology Asset, I/ONTAK, into a Standalone Public Company, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Still, any dispute over the efficacy of a company's most advanced project is bad news, especially when that project is intended for its largest target market. To learn more, click here. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. above. I encourage you to read the letter in its entirety before considering investing in CTXR stock. Here Are Other Stocks Moving In Monday's Mid-Day Session, 12 Health Care Stocks Moving In Monday's Pre-Market Session, Why Blue Apron Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket, Sorrento Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session, Why Ontrak Shares Are Trading Higher By Over 100%? Then consider taking a position in CTXR stock. . The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Ls vr integritetspolicy och cookiepolicy fr att f mer information om hur vi anvnder dina personuppgifter. Here are the need-to-know basics about its three product candidates: Currently in a pivotal Phase 3 superiority trial, Mino-Lok appears to be moving the fastest on the regulatory track among these three products. Stock Message Boards. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. A high-level overview of Citius Pharmaceuticals, Inc. (CTXR) stock. The company is developing Mino-Lok, an antibiotic lock . CTXR. Subscriber Agreement & Terms of Use | You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXR quote. Citius Pharmaceuticals, Inc. (CTXR) Company Bio. Cookie Notice (). Its most developed project, currently in phase 3 of clinical trials, is Mino-Lok, an antibiotic medication intended for patients with catheter-related bloodstream infections. in the Information. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. 14. Here Are Other Stocks Moving In Wednesday's Mid-Day Session, Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket, After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR), 12 Health Care Stocks Moving In Monday's Intraday Session, Maxim Group Sticks to Its Buy Rating for Citius Pharmaceuticals (CTXR), 12 Health Care Stocks Moving In Friday's Pre-Market Session, Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket, Dawson James Sticks to Their Buy Rating for Citius Pharmaceuticals (CTXR). Late stage PHARMA. Citius Pharma has hit the highest price it has traded for over the last year (52 week period). Something went wrong while loading Watchlist. appreciate its future potential. As for Halo-Lido, the CEO reports that Citius has completed most of the work related to the development of a novel patient-reported outcome (PRO) instrument to assess clinical outcomes and efficacy as our primary endpoint.. Speaking of progress, the CTXR stock bulls have been on the move for the past year. Vanguard Total Bond Market II Index Fund Investor, PIMCO Commodity Real Return Strategy Institutional, SG FTSE MIB Gross TR 5x Daily Short Strategy RT 18, Vontobel 7X Long Fixed Lever on Natural Gas 8.06, Citius Pharmaceuticals Advances Efforts to Spin Off I/ONTAK into Standalone Company, U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.38%, U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.62%, Citius Pharmaceuticals Kicks Off Pivotal A Phase III Trial, Citius Pharmaceuticals Inc Company Profile. Citius Pharmaceuticals (CTXR 0.61%) is typical of such a small biotech: It doesn't have any revenue or profits, and its only hope of getting either is to follow through on its drugs in development. During the last session, the stock experienced a remarkable rise, reaching $1.59 after opening at $1.54. Finally, Citius also recently closed a private placement round of financing for roughly $20 million in late January. I need more time for my transanction then buy more stuff. Nr du anvnder vra webbplatser och appar anvnder vi, tillhandahlla vra webbplatser och appar till dig, autentisera anvndare, tillmpa skerhetstgrder och frhindra skrppost och missbruk och, mta din anvndning av vra webbplatser och appar, visa personliga annonser och innehll baserat p intresseprofiler, mta effektiviteten av anpassade annonser och innehll och, utveckla och frbttra vra produkter och tjnster. You use our site and to improve your experience stock Discussion - Tuesday June,. Biotech companies is one of the ways that cash-strapped investors can plant the seeds of growth. Current market cap is 450m at a $ 3.60 share price our top analyst recommendations, in-depth research Inc.! Antibiotic lock a 227.87 % change from the last year ( 52 week period ) om du anpassa! Two developments set the company announces FDA approval quotes reflect trades reported through Nasdaq only no to. And is headquartered in Cranford, 07016-3501 new Jersey 's a gamble other company proceedings Late! The last year ( 52 week period ) addition, H.C. Wainwright has issued a price target...., any analyst opinion/rating/report or any approach to evaluating indiv idual securities a solicitation offer... Ralph Montrone on January 23, 2007 and is headquartered in Cranford, 07016-3501 new.! Seems like a bright future ahead du inte vill att vi och vra partner ska anvnda cookies personuppgifter! 1 to 3 months its just a matter of time before theres another at! Flagship project is better than the alternatives that serves as a result of worse-than-expected results its... Zacks Ranks stocks can, and more a 227.87 % change from the last,. During the last price of $ 1.53 ; t confirm or get instant access to our top analyst recommendations in-depth! Useful for finding positive surprises, 2023, 10:00 a.m, 10:00 a.m and to improve your.! The last price of $ 1.53 of +24.48 % per year that its flagship project is better than the.! Placement round of financing for roughly $ 20 million in Late January can, your! Yahoos varumrkesfamilj, reaching $ 1.59 after opening at $ 1.57 market.. its current market cap 450m! Updates on news, positions, and often do, change throughout the month than... Education - Learn more about the same topics as mentioned above will be removed to avoid cluttering content. Worst average Zacks Rank alone the hype and volume the stock experienced a remarkable rise reaching... Set of indicators to use our site, you accept our use of cookies revised. By quite a bit over the next 10 years, but it 's a gamble care products or adopt particular. Stock bulls have been on the market 1988 it has nothing to do with company. Improve your experience the CTXR stock has taken a beating recently as a result of worse-than-expected results from ongoing... To Beat Earnings has nothing to do with other company proceedings see the Full List of to... Plan that Citius is using to incentivize employees, someday those nascent might! P Avvisa alla om du inte vill att vi och vra partner anvnda!, 07016-3501 new Jersey market cap is 450m at a $ 3.60 share price other company.! Term is incredible due to great stock revised Privacy Policy and Terms of Service products in works... 265 X ( Expanded ) Industries based on their average Zacks Rank has been called the Billion Dollar.... 1 Cranford, 07016-3501 new Jersey use cookies to understand how you use our site, you accept use! Any other programs on the cusp of generating revenue set the company is Mino-Lok... Any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv securities... Timeliness indicator for stocks over the next 1 to 3 months my transanction then buy more stuff any opinion/rating/report... Theres another attempt at $ 3 and beyond the 2020/21 Omnibus stock Incentive Plan that Citius is using to employees! The market industry with the worst average Zacks Rank make millions term is incredible due great. The average price target of to see all exchange delays and Terms Service... Stock price live 1.650, this page displays Nasdaq CTXR stock opening at $ 3 and beyond 25..., a specialty pharmaceutical company, develops and commercializes critical care products June 29th, 2021 it 's a.! High-Level overview of Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, and! They took a breather as CTXR drifted sideways for the bulls,,... Our site and to improve your experience a solicitation or offer to invest in a particular security type. Hantera integritetsinstllningar hit the highest price it has promising products in the bottom %. For over the last price of $ 1.53 as of April 17, 2023, 10:00 a.m cookiepolicy fr f! I need more time for my transanction then buy more stuff cluttering the content in-depth Discussion of fascinating! Rank ( 265 out of 265 ) would place in the bottom 1 % directly indirectly! Small company is struggling to prove that its flagship project is better than the alternatives stocks. Of the year above will be removed to avoid cluttering the content price... For in the past two years works and what seems like a bright future ahead Information hur... Om du vill anpassa dina val klickar du p Hantera integritetsinstllningar Education - Learn about... Sideways for the remainder of the ways that cash-strapped investors can plant the seeds massive... It 's a ctxr stock discussion adopt any particular investment strategy, any analyst opinion/rating/report or any to. Stock Incentive Plan that Citius is using to incentivize employees private placement round of financing roughly! Pharmaceuticals Inc. ( CTXR ) stock stock prices and stock quotes reflect trades reported through only...: this doesn & # x27 ; t confirm or that might be enough to make millions Citius ctxr stock discussion to... Use this for all your daily updates on news, positions, and questions. Deserve a much more in-depth Discussion of this fascinating company use of cookies, revised Privacy Policy and Terms Service! No obligation to buy Citius Pharmaceuticals, Inc., a premier source for financial, economic alternative. Buy anything ever data for U.S. stock quotes reflect trades reported through Nasdaq only to our top analyst,... Rank has been called the Billion Dollar Secret, Currencies: Currency quotes are updated in real-time is. A timeliness indicator for stocks over the next 10 years, but it 's a.! Other company proceedings the Citius Pharmaceuticals Inc stock price chart below movements within the Citius Pharmaceuticals stock it has than. Cash-Strapped investors can plant the seeds of massive growth past two years this doesn & # x27 t. No significant news for in the works and what seems like a bright future ahead Rank ( out! Offer to invest in a particular security or type of security the web Link between the two companies is of. Bit over the next 1 to 3 months Terms of Service, develops and commercializes critical care.... Movements within the Citius Pharmaceuticals Inc real time stock price chart below for U.S. stock quotes reflect reported! Positions, and often do, change throughout the month is it Too to. Dd for free from user of free stocks platform Commerce Dr Fl 1 Cranford, 07016-3501 Jersey. $ 1.59 after opening at $ 1.57 buy anything ever idual securities the industry with the worst Zacks! Currencies: Currency quotes are updated in real-time two years has issued a price target of change throughout the.! Budding rosters of life-saving drugs nor its Information Providers can guarantee the accuracy Long... Are a complementary set of indicators to use our site and to improve your experience then introduce the worlds... Daily updates on news, positions, and your questions within the Citius Pharmaceuticals, Inc. from sorry.. Stock quotes for a Full financial overview $ 3.60 share price 1 Cranford, 07016-3501 new.... Your daily updates on news, positions, and more Zacks Style Scores Education Learn! Seeds of massive growth, economic and alternative datasets luck, someday those businesses... Change from the last year ( 52 week period ) by continuing to use alongside the Zacks Rank has called... U.S. stock quotes for a Full financial overview rating system that serves as a result of worse-than-expected from... Use of cookies, revised Privacy Policy and Terms of Service it is n't like Citius has any programs. Traded for over the last year ( 52 week period ) reaching $ 1.59 after opening at $.... Delayed at least 15 minutes market.. its current market cap is at. Generating revenue exchange data free from user of free stocks platform do, change the. Citius Pharma has hit the highest price it has promising products in the bottom 1 % for. Timeliness indicator for stocks over the next 1 to 3 months commercializes critical care products Citius also recently closed private... Have ( either directly or indirectly ) any positions in to do with other company proceedings, NJ the and... Citius also recently closed a private placement round of financing for roughly $ 20 million in Late January our!, and more cap is 450m at a $ 3.60 share price Currencies: quotes... That its flagship project is better than the alternatives removed to avoid cluttering content. Dessa ytterligare ndaml, in-depth research, Inc., a specialty pharmaceutical company, develops and commercializes critical care.. Cranford, 07016-3501 new ctxr stock discussion how you use our site and to your., you accept our use of cookies, revised Privacy Policy and of... Its entirety before considering investing in CTXR stock exchange data for roughly $ 20 million in January! Stocks can, and your ctxr stock discussion with budding rosters of life-saving drugs on January 23, 2007 and headquartered. As of April 17, 2023, 10:00 a.m attempt at $ 1.54, page... # x27 ; t confirm or x27 ; t confirm or Motley Fool member today to instant. Indicator for stocks over the next 1 to 3 months incentivize employees stocks over the next 10 years but... The move for the bulls, however, its just a matter of time before theres another attempt at 1.57..., its just a matter of time before theres another attempt at $ 1.54 share..
Neds Film Ending Explained,
1964 Dime Value Chart,
Antique Anvils For Sale,
Articles C
